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Introduction    
INTRODUCTION 
 
Myocardial infarction or necrosis of myocardial cells is one of the 
commonest diagnoses in hospitalised patients. It is one of the three main 
killers of  mankind , ie , Myocardial infarction, cerebrovascular 
accidents and cancer . Myocardial Infarction is a serious complication of 
Atherosclerotic Coronary Heart Disease
1
. In 2001, it was estimated that 
worldwide, ischemic heart disease was responsible for 11.8 percent of 
all deaths (5.7 million) in low-income countries and 17.3 percent (1.36 
million) of all deaths in high-income countries. One-third of Acute 
myocardial infarction are caused by an acute ST-segment elevation 
myocardial infarction (STEMI)
2
. The incidence of AMI
3
 has declined 
over the past two decades from 244 per 100,000 population in 1975 to 
184 per 100,000 population in 1995
4
.  
Coronary Heart Disease was first described by William Herberden 
in 1768. In 1932 , unipolar leads were discovered by Wilson and the 
establishment of coronary care units by Day and Brown has lead to the 
world wide proliferation of coronary care units. The current knowledge of 
pathophysiology of acute myocardial infarction started with the autopsy 
description of Dr. James Herrick from Chicago in 1912 who concluded 
that acute myocardial infarction results from thrombotic occlusion of 
coronary artery and prophesized that the hope of salvaging the muscle, 
lay in restoration of blood flow. In the landmark paper by Herrick
5
, he 
wrote, “The clinical manifestations of coronary obstruction will evidently 
vary greatly depending on the size, location and number of vessels 
occluded. The symptoms and end-result must also be influenced by blood 
pressure, by the condition of the myocardium not immediately affected 
by the obstruction, and by the ability of the remaining vessels to properly 
carry on their work, as determined by their health or disease” 
Myocardial Infarction6 is an acute cardiac disability arising from 
reduction or arrest of blood supply to the myocardium due to 
atherosclerotic or non-atherosclerotic lesions of coronary arteries. 
Virtually all acute infarcts are caused by thrombosis developing in a 
culprit vessel with ruptured atherosclerotic plaque. Usually coronary 
artery occlusion is associated with infarction of myocardium, though 
post-mortem examination of cases of sudden deaths reveals evidence in 
only 20% of cases, the remaining 80% not showing any change. 
The incidence of myocardial infarction
7
 increases with both sex 
and social class. It is three to four times more frequent among men than 
women . The popular concept that coronary artery disease is the scourge 
of the managerial and industrial class appears to be wrong . Recent 
surveys suggest that myocardial infarction is substantially more 
common among manual and skilled workers.This observation is only 
partially explained in terms of classical risk factors. Approximately 40 – 
50 % of patients experiencing a heart  attack die within 20 days of the 
onset . Elderly patients invariably fare less well than the young and 
middle aged . Half the deaths occur between 1 and 2 hours of the onset 
of symptoms . Many patients therefore fail to reach the hospital , 
succumbing to the potentially correctable ventricular  fibrillation. In 
contrast , a person  surviving long enough to gain admission to hospital 
is more likely to die as a result of pump failure , intractable left 
ventricular failure or cardiogenic shock for which even the best coronary 
care unit can do little. 
Mortality from STEMI has declined steadily in several population 
groups since 19608,9.  This drop in mortality appears to result from a fall 
in the incidence of STEMI (replaced in part by an increase in the rate of 
unstable angina/non-ST-segment elevation MI
10
) and a fall in the case 
fatality rate once STEMI has occurred11.Several phases in the 
management of patients have contributed to the decline in mortality 
from STEMI
12
. The “clinical observation phase” of coronary care 
consumed the first half of the 20th century and focused on a detailed 
recording of physical and laboratory findings, with little active treatment 
for the infarction
13
. The “coronary care unit phase” began in the mid-
1960s and was notable for detailed analysis and vigorous management 
of cardiac arrhythmias. The “high-technology phase” was ushered in by 
the introduction of the pulmonary artery balloon floatation catheter, 
setting the stage for bedside hemodynamic monitoring and more precise 
hemodynamic management. The modern “reperfusion era” of coronary 
care was introduced by intracoronary and then intravenous fibrinolysis, 
increased use of aspirin, and development of primary percutaneous 
coronary intervention (PCI) 
Accurate diagnosis is mandatory because mistaken diagnosis can 
be disastrous to the social, economical and family life of the patient. At 
one end of the spectrum is the danger of missing a potentially lethal 
illness, on the other hand mistaken diagnosis results in severe cardiac 
neurosis which is even more difficult to treat than the original disease 
itself. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Aim of the  study          
AIM OF THE STUDY 
 
The aims of the study are : 
 
1. To find out the overall incidence of anterior and inferior wall 
myocardial infarction. 
 
2. To compare the incidence and mortality rate of anterior and inferior 
wall myocardial infarction in relation to age , sex and occupation. 
 
3. To compare the effects of various risk factors on anterior and 
inferior wall myocardial infarction. 
 
4. To compare the incidence and mortality rate of anterior and inferior 
wall myocardial infarction , with reference to Killip’s classification 
of left ventricular failure . 
 
5. To compare the incidence of arrhythmias  in anterior and inferior 
wall myocardial infarction and mortality due to arrhythmias . 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Review of Literature            
REVIEW OF LITERATURE 
 
A. ANATOMY OF CORONARY CIRCULATION
14
 (Fig 1) 
 
 
Right coronary artery (RCA) 
The right coronary artery originates from the right aortic sinus of the 
ascending aorta. During this course, several branches arise from the main 
stem of the vessel:  
• an early atrial branch passes in the groove between the right 
auricle and ascending aorta, and gives off the sinu-atrial nodal 
branch to supply the sinu-atrial node;  
• a right marginal branch is given off and continues along this 
border toward the apex of the heart;  
• a small branch to the atrioventricular node  
• before giving off its final major branch, the posterior 
interventricular branch,  
The right coronary artery supplies the right atrium and right ventricle, the 
sinu-atrial and atrioventricular nodes, the interatrial septum, a portion of 
the left atrium, the posteroinferior one-third of the interventricular 
septum, and a portion of the posterior part of the left ventricle 
 
Left coronary artery (LCA) 
The left coronary artery originates from the left aortic sinus of the 
ascending aorta. While still posterior to the pulmonary trunk, the artery 
divides into its two terminal branches, the anterior interventricular and 
the circumflex .  
• the anterior interventricular branch (left anterior descending 
artery-LAD), which continues around the left side of the 
pulmonary trunk and descends obliquely toward the apex of the 
heart in the anterior interventricular sulcus.  
•  the circumflex branch,  ends before reaching the posterior 
interventricular sulcus- 
• a large branch, the left marginal artery, 
The distribution pattern of the left coronary artery enables it to 
supply most of the left atrium and left ventricle, and most of the 
interventricular septum, including the atrioventricular bundle and 
its branches. 
In 85% of patients, the right coronary artery which gives rise to 
posterior descending artery supplies the entire right ventricle and large a 
part of the posterior wall of the left ventricle. This is referred to as right 
dominant circulation. 
 In 8% of patients the left coronary artery supplies entire left 
ventricle, interventricular septum and a portion of right ventricle. This is 
referred to as left dominant circulation . 
Fig 1 
 
 
 
B.DEFINITION OF MYOCARDIAL INFARCTION 
Epidemiological reports from the World Heath Organization and 
American Heart Association beginning in the late 1950s required the 
presence of at least two of the following for the diagnosis of myocardial 
infarction: characteristic symptoms, electrocardiographic changes, and a 
typical rise and fall in biochemical markers
15
. 
 
 
Revised Definition of Myocardial Infarction
16(
Table 1) 
 
Table 1 
Criteria for Acute, Evolving, or Recent MI 
Either of the following criteria satisfies the diagnosis for acute, evolving, 
or recent MI: 
   
1.    Typical rise and/or fall of biochemical markers of myocardial 
necrosis (CK-MB  or troponin)with at least one of the following:  
   a)    Ischemic symptoms  
   b)    Development of pathological Q waves in the ECG  
   
c)     ECG changes indicative of ischemia (ST segment 
elevation or depression)  
   
d)    Imaging evidence of new loss of viable myocardium or 
new regional wall motion abnormality  
 
   2.    Pathological findings of an acute myocardial infarction  
 
Criteria for Healing or Healed Myocardial Infarction 
Any one of the following criteria satisfies the diagnosis for healing or 
healed myocardial infarction: 
   
1.    Development of new pathological Q waves in serial ECGs. The 
patient may or may not remember previous symptoms. 
Biochemical markers of myocardial necrosis may have 
normalized depending on the length of time that has passed since 
the infarction developed.  
   2.    Pathological findings of a healed or healing infarction  
 
 
Following disruption of a vulnerable plaque, patients experience ischemic 
discomfort resulting from a reduction of flow through the affected 
epicardial coronary artery. Of patients with ST-segment elevation, the 
majority ultimately develop a Q-wave on the ECG (QwMI), while a 
minority  do not develop Q-wave and in older literature were said to have 
sustained a non-Q-wave MI (NQMI). Patients who present without ST-
segment elevation are suffering from either unstable angina or a non-ST-
segment elevation MI (NSTEMI) , a distinction that is ultimately made 
on the presence or absence of a serum cardiac marker such as CKMB or a 
cardiac troponin detected in the blood. The majority of patients 
presenting with NSTEMI do not develop a Q-wave on the ECG; a 
minority develop a QwMI
17
 .(Fig 2) 
 Fig 2. Scheme for diagnosis of Myocardial Infarction 
 
C.AETIOPATHOGENESIS OF MYOCARDIAL INFARCTION 
1.ATHEROSCLEROSIS
18,19,20
 
Atherosclerosis is characterized by formation of atheroma or fibro 
fatty plaque which consists of a raised focal plaque within the intima, 
having a core of lipid and a covering of fibrous cap. (Fig 3) 
Atherosclerosis
21,22,23
 is the single most important etiological factor for 
coronary heart disease. The search for the cause and pathogenesis of 
atherosclerosis
24,25,26
 has become an insistent “golden grail”. The 
acceptable hypotheses  are: 
 
  
Fig 3. Fatty-streak formation in atherosclerosis 
 
A) LIPID INSUDATION OR INFILTRATION HYPOTHESIS: 
This is the modified “imbibition hypothesis”
27
termed by Virchow 
in 1856 which stated that cellular proliferation in intima was a form of 
low grade inflammation as a reaction to increased infiltration of plasma 
protein and lipids
28
 from the blood. 
 
B)  ENCRUSTATION OR THROMBOGENIC HYPOTHESIS: 
This theory ascribed to Rokitansky, postulated that small thrombi 
composed of platelet, fibrin and leukocytes collected over foci of 
endothelial injury organized and their gradual growth resulted in plaque 
formation
29,30 
 
 C)  REACTION TO INJURY HYPOTHESIS: 
This widely accepted theory formulated by Ross
31
 and Glomset in 
1976 and modified in 1986
32,33
 states that the lesions of atherosclerosis 
are initiated as a response to some form of injury to arterial endothelium. 
Endothelial injury leads to attachment of monocytes and platelets, 
proliferation of smooth muscle cells in the arterial intima and deposition 
of intracellular and extracellular lipids. 
D  INFLAMMATION THEORY 
In his most recent review of the pathogenesis of atherosclerosis ,                     
Ross
34
  continues to state the importance of endothelial dysfunction in the 
origin of atherosclerosis but also highlights the role played by             
inflammation  at every step of the pathogenesis of atherosclerosis. 
  
1.NON-ATHEROSCLEROSIS 
35,36 
Non-atherosclerotic
37,38,39
 causes of Myocardial Infarction
,40,41,42
 are 
1. Congenital anomalies like single coronary artery, atresia of 
coronary ostium, myocardial bridges, coronary AV fistula 
etc. 
2. Dissection of coronary artery or aorta. 
3. Embolic phenomena from prosthetic valves, infective 
endocarditis, tumors, calcium, paradoxical embolus, etc. 
4. Traumatic injury or spasm of coronary artery. 
5. Coronary arteritis due to Takayasu Disease, Polyarteritis 
Nodosa, SLE, Syphilis, Kawasaki Disease 
6. Metabolic disorders like Mucopolysaccharidoses, 
Homocystinuria, Fabry’s Disease and Amyloidosis. 
7. Substance abuse like cocaine, amphetamine. 
8. Myocardial oxygen demand-supply disproportion due to 
aortic stenosis, systemic hypotension, carbon monoxide 
poisoning, thyrotoxicosis. 
9. Intimal proliferation due to irradiation, cardiac 
transplantation, fibro muscular hyperplasia. 
10. Miscellaneous cause like HOCM, hypercoagulable states, 
diabetes mellitus.  
3.  RISK FACTORS FOR MYOCARDIAL INFARCTION 
43,44,45
(TABLE 1) 
The term risk is widely used to describe those characteristically found in 
healthy individuals that relate to the subsequent appearance of 
Ischaemic Heart Disease46,47,48. The risk of Ischaemic Heart 
Disease
49,50,51
 is determined by the aggregation of individual factors.  
Table 1: RISK FACTORS FOR CORONARY HEART DISEASE 
A. FIXED 
1. Age 
2. Male sex 
3. Family History 
B. MODIFIABLE 
1. Smoking 
2. Hypertension 
3. Lipid Disorders 
4. Diabetes Mellitus 
5.Haemostatic variables 
6. Sedentary Life Style 
7. Obesity 
8. Mental Stress 
9. Personality 
10. Oral Contraceptive Pills 
11. Hyperhomocysteinemia 
12. Inflammation 
 
1. AGE: 
Age
52,53
 is a definite unmodifiable risk factor. Atherosclerosis 
develops progressively as age advances. Men acquire an independent 
risk factor at age 45, Women acquire an independent risk factor at age 
55 .  Atherosclerosisis rarely present in early childhood, except in 
familial hyperlipidemia, but it is often detectable in postmortem 
specimens of young age between 15-30 years. Atherosclerosis is 
universal in elderly. 
2. SEX: 
 Men are more affected than premenopausal women. However 
after menopause the incidence of atheroma rises in women
54,55,56
. This 
suggests that oestrogen probably plays a part in preventing or delaying 
atherosclerosis. There is also a fall in HDL levels in postmenopausal 
women which may also contribute. 
3. FAMILY HISTORY: 
 Coronary artery disease runs in families. This may be due to 
genetic factors or the effects of a shared environment (similar diet, 
smoking habits etc,). A positive family history
57,58
 is generally accepted 
to refer to those patients in whom a first degree relative of the patient 
has developed Ischaemic Heart Disease before the age of 50 years. 
4. SMOKING:
59,60 
 Tobacco is probably the most important avoidable cause of 
coronary disease. The incidence of Ischaemic Heart Disease is 3-5 times 
higher in smokers who smoke 20 cigarettes per day compared to non-
smokers. There is a strong, consistent and dose linked relationship 
between cigarette smoking
61,62
 and Ischaemic heart disease. The 
incidence of sudden death is also higher in smokers. Smoking decreases 
HDL cholesterol levels. It accelerates atherosclerosis, plaque instability, 
increases the risk of thrombosis, myocardial infarction and death.  
 
5. HYPERTENSION
63,64,65
 
 The incidence of coronary heart disease increases as blood 
pressure rises and the excess risk is related to both systolic and diastolic 
blood pressure
66,67
. In the Framingham study, the incidence of Coronary 
Artery Disease in middle aged persons with blood pressure exceeding 
160/95mmHg was 5 times more than that in normotensive men.  For each 
10mmHg increase in Diastolic Blood Pressure there is 37% increase in 
risk of Coronary Heart Disease. Antihypertensive drugs have shown to 
reduce coronary mortality particularly by interruption of renin 
angiotensin system. 
 
6. LIPID DISORDERS
68,69,70
: 
 A wealth of evidence from epidemiological, clinical and 
experimental studies has established the association between 
hyperlipidemia
71
 and atherosclerosis. Hypercholesterolemia is clearly a 
risk factor. 
Of the lipoprotein, it is the low density lipoprotein (LDL) which 
is most atherogenic. VLDL is comparatively less atherogenic. HDL 
offers a protective effect and helps in removing cholesterol from the 
arterial wall. The ratio of LDL/HDL is a common way to assess 
atherogenicity of hyperlipidemia. A ratio of more than 4.5 is supposed 
to be atherogenic. A minor increase of 1mg/dl in HDL-4 Cholesterol 
produces a 2-4% decrease in the risk of developing Acute Myocardial 
Infarction. 
The LDL cholesterol profiles are categorized as phenotypic 
pattern A, B and C. Patients with pattern B have mostly small, dense 
LDL particles. Small, dense LDL particles have been causally linked to 
an increased risk of coronary artery disease independent of total LDL 
cholesterol levels. It has been suggested that small dense LDL particles 
are more atherogenic because of greater retention in the arterial wall and 
increased susceptibility to oxidation. 
There is increasing evidence that hypertriglyceridemia is 
independently linked with coronary atheroma even after adjustment for 
HDL levels 
7. DIABETES MELLITUS
72,73
: 
 Diabetes Mellitus74 is a coronary heart disease risk equivalent. 
The abnormal lipid profile with insulin resistance known as Diabetic 
Dyslipidemia (small dense LDL, low HDL, elevated triglyceride) 
account for part of elevated cardiovascular risk. Diabetes increases the 
frequency of atherosclerosis. It is likely that post prandial 
hyperglycemia may be more important in the development of coronary 
artery disease than fasting hyperglycemia.  Diabetic women are 5-6 
times more prone for coronary heart disease
 
compared to men. 
8. HAEMOSTATIC FACTORS
75,76 
 High levels of fibrinogen and factor 7 are associated with 
increased risk of myocardial infarction. Polymorphism of factor 7 gene 
may increase the risk of Myocardial Infarction. The stability of an 
arterial thrombus depends on the balance between fibrinolytic factors 
like plasmin and inhibitors of the fibrinolytic system such as 
Plasminogen Activator Inhibitor (PAI) 1. However, the levels of tissue 
plasminogen activator and PAI-1 in plasma have not proven to add 
information beyond the lipid profile for assessment of cardiovascular 
risk. 
Apolipoprotein (a) has structural homology with plasminogen 
with which it is able to compete for cell surface binding. By displacing 
plasminogen, apolipoprotein (a)
77
 is able to inhibit cell surface mediated 
endogenous fibrinolysis by reducing the formation of Plasminogen 
Activator from Plasminogen. Plasma level of Lp (a) is largely 
genetically determined. Lp (a) levels do not potently predict risk in the 
population at large. 
9. SEDENTARY LIFE STYLE
78
: 
 The recent National Institute of Health Consensus Panel on 
Physical Activity and Cardiovascular Health established a goal of atleast 
30 min of moderate intensity physical activity on a daily basis. Exercise 
increases HDL cholesterol, lowers blood pressure, reduces blood 
clotting and promote collateral vessel development. 
10. OBESITY: 
 Obesity
79,80
, particularly the male pattern of centripetal or visceral 
fat accumulation is probably an independent risk factor although it can 
be associated with hypertension, diabetes mellitus and physical 
inactivity. 
11. MENTAL STRESS AND PERSONALITY: 
 Stress is associated with increased catecholamine levels and high 
blood pressure thereby increasing the risk of coronary heart disease. 
Type A individuals who are ambitious, aggressive, impatient, 
competitive, always in a hurry and often frustrated are more prone to 
Ischaemic heart disease. 
12. ORAL CONTRACEPTIVE PILLS: 
 Oral contraceptives disturb the clotting mechanism through an 
increased inactivity of factor 7 and 10. It also increases platelet 
sensitivity to ADP and hence to platelet adhesiveness. Oestrogen retards 
atherosclerosis but accelerates thrombogenesis resulting in myocardial 
infarction in the rare susceptible person. 
 
 
13. HYPERHOMOCYSTEINEMIA: 
 A large body of literature suggests a relationship between 
hyperhomocysteinemia and coronary events. Several mutations in the 
enzymes involved in homocysteine
81
 accumulation correlate with 
thrombosis and in some studies, coronary risk. Measurement of 
homocysteine levels should be reserved for individuals with 
atherosclerosis at a young age or out of proportion to established risk 
factors. 
14. INFLAMMATION
82
: 
 An accumulation of clinical evidence shows that markers of 
inflammation correlate with coronary risk. Inflammatory cells in the 
plaque may contribute to plaque destabilization by producing matrix 
degrading metalloproteinases and by inducing smooth muscle cell 
apoptosis. Inflammatory cells also contribute to plaque thrombogenicity 
by releasing tissue factor- a procoagulant protein that activates the 
clotting cascade resulting in thrombin generation which leads to platelet 
aggregation and fibrin deposition. Inflammation in atherosclerotic 
plaque may be incited by a number of factors, which include oxidized 
LDL, cigarette smoking and possibly infectious agents. Variation of 
plasma levels of CRP can prospectively predict risk of myocardial 
infarction. CRP
83
 levels also correlate with outcome of patients with 
acute coronary syndrome. Elevated levels of CRP may merely reflect 
ongoing inflammation rather than a direct etiologic role of CRP in the 
coronary artery disease. 
D. CLINICAL FEATURES
84
 (Fig 4) 
 Retrosternal chest discomfort is the cardinal symptom of 
myocardial infarction, but breathlessness, vomiting, giddiness, syncope 
are common features. Patient is anxious and experiences the fear of 
impending death. Syncope is usually due to arrhythmia or profound 
hypotension. Vomiting and  
Fig 4. Rough diagram of pain zones in myocardial infarction (dark red = 
most typical area, light red = other possible areas, view of the chest). 
 
                                                   
sinus bradycardia are often due to vagal stimulation and are particularly 
common in patients with inferior wall myocardial infarction. Many deaths 
occur within the first hour. Development of cardiac failure reflects the 
extent of myocardial damage and is the major cause of death in those who 
survive the first few hours of infarction. On examination signs of 
sympathetic activity like sweating, tachycardia may be present. Vomiting 
and bradycardia may also be present. Signs of impaired myocardial 
function like hypotension, oliguria, cold peripheries, raised JVP, muffled 
heart sounds, S3, basal crepitations, pansystolic murmurs may also be 
present. Pericardial rub may be present. 
E.INVESTIGATIONS 
1. LABORATORY FINDINGS: 
  Myoglobin levels are the earliest to rise. Creatine Kinase 
starts to rise at 4 hours, peaks at about 12 hours falls to normal levels 
within 48-72 hours 85,86. The most sensitive markers of myocardial cell 
damage are the Cardiac Troponins T and I which are released within 4-6 
hours and remain elevated for upto 2 weeks. Myoglobin levels peak at 6 
hours and returns to normal at 24 hours. Aspartate transaminase starts to 
rise about 12 hours after infarction and reaches peak on the first or 
second day returning to normal within 3 or 4 days. Lactate 
dehydrogenase peaks at 3-4 days remains elevated for upto 10 days. 
Fig 5 
Lipid profile (cholesterol – total, LDL & triglycerides) may be raised. 
Leukocytosis is usual, reaching a peak on the first day. The ESR 
becomes raised.  
2. CHEST RADIOGRAPHY (Fig 6): 
 Chest X-ray is important since it may show the consequences of 
ischaemic heart disease i.e. cardiac enlargement, ventricular aneurysm, 
signs of heart failure and pericardial effusion. These signs can support 
the diagnosis of ischaemic heart disease and are important in assessing 
degree of cardiac damage.  
Fig 6 CXR showing pericardial effusion 
 
 
3. ELECTROCARDIOGRAPHY
87,88,89
(FIG 7,8,9)(Table 2)
 
 The ECG
90
 is usually a sensitive and specific way of confirming 
the diagnosis; however it may be difficult to interpret if there is bundle 
branch block or evidence of previous myocardial infarction. 
Occasionally the initial ECG is normal and the diagnostic changes 
appear a few hours later. The earliest ECG change is tall and widened T 
waves followed by ST elevation. Later on there is diminution in the size 
of R wave and in full thickness infarction a Q wave begins to develop. 
Subsequently T wave becomes inverted. 
Table 2 
ANATOMICALZONE ECG ZONE 
INFERIOR WALL LII,III,Avf 
ANTERO SEPTALWALL V1-V4 
EXTENSIVE ANTERIOR WALL LI,AVL,V1-V6 
ANTERO LATERAL WALL LI,AVL,V5-V6 
INFERO LATERAL WALL LII,LIII,AVF,AVL,V5-V6 
 
 
 
 
 
 Fig 7. ECG showing Anterolateral wall Myocardial Infarction 
 
 
 
 
 
 
 
Fig 8. ECG showing inferior wall MI 
 
 
 
 
 
Fig 9.Anterior wall  MI 
 When there has been anteroseptal infarction, abnormalities are found in 
one or more leads from V1 to V4, while Anterolateral Infarction 
produces abnormalities in V4-V6, aVL and in lead I. Inferior Wall 
Infarction is best shown in lead II, III and aVF, while at the same time 
leads I, aVL and the anterior chest leads may show reciprocal changes 
of ST depression. Infarction of the posterior wall of the left ventricle is 
not recorded in the standard leads by ST elevation or Q waves, but the 
reciprocal changes of ST depression and a tall R wave may be seen in 
leads V1-V3. Right ventricular infarction should be strongly suspected 
if, in the clinical setting of acute inferior wall myocardial infarction, 
there is ST elevation of 1mm or more in lead V1, V4R or any of the 
extra right precordial leads V4R-V6R. 
4. ECHOCARDIOGRAPHY (Fig 10): 
 Two dimensional echocardiography 
91
can be done to assess the 
cardiac chamber size, regional wall motion abnormalities, left 
ventricular hypertrophy, valve leaflet thickness and mobility, valve 
calcification, appearance of subvalvular and supravalvular structures, 
pericardial effusion, intracardiac masses and great vessels. 
  Doppler echocardiography is done to assess valve regurgitation, 
valve stenosis, valve area, valve gradients, intracardiac pressures, 
intracardiac shunts and ventricular diastolic filling. 
 Transesophageal echocardiography is used to assess aortic 
disease, infective endocarditis, to find out source of embolism, 
abnormalities of mitral prostheses etc.  
 Stress echocardiography is done to find out new regional wall 
motion abnormalities, declining ejection fraction and increase in end 
systolic volume which are indicators of myocardial ischemia. 
 
 Fig 10. ECHO SHOWING ACUTE MITRAL REGURGITATION 
 
 
5. RADIONUCLIDE SCANNING: 
 A radionuclide ventriculogram can be used to assess left 
ventricular function. Infarct ‘avid’ scanning is possible because some 
isotopes (e.g. Technetium) are taken up by freshly infarcted myocardium. 
This may help to establish the diagnosis in some patients who present 
after a cardiac arrest when it is sometimes difficult to interpret any ECG 
and enzyme changes. 
 
F. COMPLICATIONS OF MYOCARDIAL INFARCTION  
1. ARRHYTHMIAS
92,93
: 
A. TACHYARRYTHMIAS: 
a. Premature ventricular complexes: 
 The commonest arrhythmia is premature ventricular complexes. 
This can be suppressed with IV lignocaine 100mg given as bolus. To 
prevent recurrence , lignocaine infusion of 500-1000mg in 500ml of 5% 
dextrose is administered at a rate of 1-2mg/min. premature ventricular 
complexes can be forerunners of life threatening ventricular tachycardia 
or ventricular fibrillation. 
b. Ventricular Tachycardia: 
 It needs immediate attention and should be treated by IV 
lignocaine. In case the drug is ineffective, DC shock of 150-200 joules 
will be effective in majority of the cases. Repeated attacks of 
ventricular tachycardia can be prevented by IV infusion of lignocaine, 
amiodarone or mexilitene.  
c. Ventricular Fibrillation:  
 The patient is pulseless and will have features of cardiac arrest. 
Immediate thump on the chest and an external cardiac massage is 
required. Defibrillation should be one by DC shock of 200-400 joules. 
Patients with repeated episodes may benefit from intravenous 
bretylium, amiodarone, mexilitene or lignocaine. 
d. Supraventricular Arrhythmias 
  Atrial premature beats do not need specific treatment. However 
supraventricular arrhythmia, atrial flutter and atrial fibrillation require 
treatment with digoxin or verapamil. 
e. Accelerated Ventricular or Junctional Rhythm: 
 Normally pace maker cells in the AV junctional and ventricular 
myocardium have a rate of 40-60/min. however in the settings of 
myocardial infarction, especially in acute inferior wall myocardial 
infarction, the rate of these pacemakers increases to about 80-120/min. 
Such a rhythm does not require specific treatment and is normally self 
limiting. If hemodynamic compromise occurs IV atropine (1.2mg) 
suppresses it by increasing the sinus rate. 
B. BRADYARRHYTHMIAS AND CONDUCTION 
DISTURBANCES: 
a. Sinus Node Dysfunction: 
 It may present as sinus bradycardia, sinus arrest or sinoatrial 
block usually due to vagal stimulation or in the settings of inferior wall 
infarction due to sinus node ischaemia. Symptoms of profound 
hypotension and shock may occur and occasionally asystole and cardiac 
arrest. Immediate treatment consists of IV atropine (1.2mg). If atropine 
is ineffective or this problem is persistent or recurring temporary pace 
making is necessary. 
b. AV Nodal Block: 
 It usually occurs with inferior wall myocardial infarction as first 
degree AV block, Wenkebach’s block or complete AV block. These 
blocks are usually transient and respond to IV atropine. If giddiness, 
hypotension or other evidence of hemodynamic compromise occurs or 
if the ventricular rate is less than 50/min temporary pacing may be 
required. 
c. Distal Conduction Disturbances: 
 The distal conduction system consists of the right bundle and the 
anterior and posterior fascicles of the left bundle. Since the major blood 
supply to this part of the conduction system comes from the left 
coronary artery, conduction defects in the bundle branches are common 
in anterior wall infarction. Block of one of the fascicles of the left 
bundle does not have an ominous prognosis. However acute right or left 
bundle branch block or bifascicular block carries an ominous prognosis. 
Block in the three fascicles results in complete heart block with an 
unstable ventricular escape rhythm at a rate of 20-40 beats per minute. 
Clinical manifestations consists of syncopal attacks, hypotension and 
may lead to cardiac arrest. Temporary pacemaker insertion is necessary. 
Temporary pacing is also indicated in patients who develop bifascicular 
blocks since this can be a precursor of trifascicular block. Patients with 
bifascicular block who develop trifascicular block may need permanent 
pacemaker implantation. 
 
2. ISCHAEMIA: 
 Post infarction angina occurs in upto 50% of patients. This is due 
to residual stenosis in infarct related vessel despite successful 
thrombolysis. 
 
3. ACUTE CIRCULATORY FAILURE: 
 Hemodynamic evidence of left ventricular dysfunction appears 
when contraction is seriously impaired in 20-25% of the left ventricle. 
Infarction of more than 40% of left ventricle results in cardiogenic 
shock which carries a bad prognosis. 
 
4. PERICARDITIS: 
 This may occur at any stage but is particularly common on the 
second and third day. The patient may recognize a different pain that is 
positional and worsens on inspiration. Dressler’s Syndrome may occur 
between 2 weeks and 3 months after acute myocardial infarction and has 
an autoimmune basis often accompanied by pleural and pericardial 
effusions, fever and raised ESR. Treatment requires the use of steroids. 
5. MECHANICAL COMPLICATIONS: 
a. Mitral regurgitation
94
:
 
 It is due to ischaemia or rupture of papillary muscle and is 
recognized by the presence of systolic murmur at the apex. If trivial, it is 
of no hemodynamic significance. However severe mitral regurgitation 
can induce life threatening left ventricular failure and cardiogenic shock 
and may warrant urgent coronary angiography followed by coronary 
bypass surgery and mitral valve replacement. 
b. Ventricular septal defect: 
 It is a defect due to rupture
95
 of infarcted interventricular septum 
and is recognized by the presence of pansystolic murmur at the left 
sternal border. Diagnosis is possible by Echo-Doppler studies. It 
produces severe left heart failure and needs immediate surgical 
intervention. 
c. Cardiac Rupture
96
: 
 It is a serious complication which results in cardiogenic shock and 
almost 100% mortality. Emergency treatment by pericardial tapping 
may prove life saving. Rare cases have been saved by emergency 
surgery. 
 
 
 
6. OTHER COMPLICATIONS
97
: 
a. Left Ventricular Aneurysm: 
 The infarcted segments are dilated and show paradoxical 
movement and compromised left ventricular hemodynamics. It is 
recognized by persistent ST elevation in ECG and dyskinesia seen in 
echocardiography and radionuclide or contrast ventriculography. It may 
result in persistent left ventricular failure, arrhythmias and systemic 
embolism. Treatment consists of aneurysmectomy and associated 
coronary artery bypass surgery if so indicated. 
 
b. Thromboembolism:  
 Formation of a thrombus within the left ventricle followed by 
systemic arterial embolism leading to occlusion of a peripheral artery 
requires immediate  surgical embolectomy. Pulmonary embolism 
originates in the leg veins due to prolonged immobilization. These are 
prevented by anticoagulation. Thrombolytic therapy and embolectomy 
are occasionally required. The condition can be prevented by low 
molecular weight heparin. 
 
KILLIPS CLASSIFICATION OF HEART FAILURE
98
(Table 3) 
Killip classified patients with MI into 4 classes based on findings of left 
ventricular failure by physical examination at time of admission into 
CCU.Hospital mortality from MI depends directly on severity of LV 
Dysfunction at time of admission. 
Table 3 
 
Class Definition Approx 
mortality(%) 
Class I Absence of rales over lung fields and 
absence of S3 
8 
Class II Rales over 50% or less of lung fields 
or presence of S3 
30 
Class III Rales over more than 50% of lung 
fields(pulmonary edema) 
44 
Class IV Cardiogenic shock 80 to 100 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Materials & Methods 
MATERIALS AND METHODS 
 
The present study is based on 100 cases of myocardial infarction 
admitted in I.C.C.U in Coimbatore medical college hospital during a 
period of one year.It is a descriptive study. Sampling was done by 
purposive non probability sampling .In each case , the following details 
were gathered and recorded .Age, sex ,occupation , diet , history of 
smoking , diabetes mellitus , hypertension and  previous myocardial 
infarction were recorded . Thorough physical examination  was done in 
each patient at the time of admission into the I.C.C.U. All the 100 cases 
were divided into 4 classes according to Killip’s  classification . 
Investigations like Hb, TC , DC, ESR, blood sugar, blood urea, serum 
creatinine, urine analysis, serum cholesterol , triglycerides and HDL were 
done and recorded in each case . ECG was done in all cases to confirm 
the diagnosis of myocardial infarction and to find out the type of 
infarction. In many cases, serial ECG’s were taken to show the progress 
and prognosis. In many cases, Chest x-rays were taken. 
 
Echocardiography evaluation was also done . Treatment particulars 
were carefully recorded and followed. Each patient was followed up 
during the stay in the hospital to assess the prognosis . Attempt has been 
made to compare the two types of infarctions – anterior and inferior wall 
infarctions in relation to age, sex, occupation, risk factors and 
complications including with reference to Killip’s classification . 
 
Patients  who had previous hospitalisation for ischemic heart 
disease were excluded from this study . Patients with non ST elevation 
myocardial infarction were excluded from the study.  Patients who had 
both anterior and inferior wall myocardial infarction were also excluded 
from this study. 
 
The relevant information was entered into a specially designed   
proforma. All the data collected through the proforma was analyzed 
through SPSS version 17 in terms of frequency, percentages and 
proportions. 
 
  
 
 
 
Results and  observation                  
RESULTS AND OBSERVATION 
 
INCIDENCE IN RELATION TO AGE (Graph 1) 
Out of 100 patients,39 were in the 50- 60 age group , of  which 25 
(64.1%) patients were anterior wall MI  and 14 (35.9%) were inferior 
wall MI. 
Graph 1 
 
 
 
AGE (yrs) TOTAL ANTERIOR 
WALL MI 
INFERIOR 
WALL MI 
>70 8 5(62.5%) 3(37.5%) 
60-70 13 8(61.5%) 5(38.5%) 
50-60 39 25(64.1%) 14(35.9%) 
40-50 27 18(66.7%) 9(33.3%) 
30-40 9 6(66.7%) 3(33.3%) 
<30 4 3(75%) 1(25%) 
There is no significant difference between anterior and inferior wall MI in 
relation to age. 
 
INCIDENCE IN RELATION TO SEX(Graph 2) 
 
 
Out of 100 patients,84 were male  and 16 were female.Of the males,53 
(63.1%) were anterior wall MI and 31(36.9%) were inferior wall MI. Of 
females, 12 (75%)were anterior wall MI and 4(25%) were inferior wall 
MI. 
Graph 2 
 
 
There is no significant difference between anterior wall MI and inferior 
wall MI in relation to sex. 
SEX TOTAL ANTERIOR 
WALL MI 
INFERIOR 
WALL MI 
MALE 84 53 (63.1%) 31 (36.9%) 
FEMALE 16 12 (75%) 4 (25%) 
INCIDENCE IN RELATION TO OCCUPATION(Graph 3) 
The patients were divided into 3 groups based on occupation 
OCCUPATION TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
Sedentary work 10 5(50%) 5(50%) 
Moderate 
exertion 
24 14(58.3%) 10(41.7%) 
Manual labourer 66 46(69.7%) 20(30.3%) 
 
Out of the 100 patients, 66 were manual labourers of which 46(69.7%) 
were anterior wall MI and 20 (30.3%)were inferior wall MI. 
Graph 3 
 
There is no significant difference between anterior and inferior wall MI 
in relation to occupation 
 
INCIDENCE IN RELATION TO SITE OF INFARCTION(Graph 4,5) 
 
The site of infarction was determined by ECG analysis 
ANATOMICAL ZONE ECG ZONE 
INFERIOR WALL LII,III,Avf 
ANTERO SEPTALWALL V1-V4 
EXTENSIVE ANTERIOR WALL LI,AVL,V1-V6 
ANTERO LATERAL WALL LI,AVL,V5-V6 
 
SITE OF INFARCTION NO: OF PATIENTS 
ANTERIOR WALL 65 
ANTEROSEPTAL 30(46.2%) 
ANTEROLATERAL 16(24.6%) 
EXTENSIVE ANTERIOR WALL 19(29.2%) 
INFERIOR WALL 35 
 
Out of the 100 patients, 65 were anterior wall MI and 35 were inferior 
wall MI.Out of  the anterior wall MI patients, 30 (46.2%)were 
anteroseptal,16(24.6%) were anterolateral and 19(29.2%) were 
extensive anterior wall MI. 
 
Graph 4 
 
 
Graph 5 
 
 
HYPERTENSION(Graph 6) 
The role of hypertension as a risk factor was assessed . 
HYPERTENSION TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
TOTAL 51 33(65%) 18(35%) 
MALE 41 27(66%) 14(34%) 
FEMALE 10 6(60%) 4(40%) 
 
Out of  the 51  patients with hypertension , 33 were anterior wall MI and 
18 were inferior wall MI. 
Graph 6 
 
There is no significant difference between anterior wall and inferior wall 
MI  in relation to hypertension as a risk factor 
 
DIABETES(Graph 7) 
The role of diabetes as a risk factor was also studied. 
 
Out of the 32 patients with diabetes ,21 were anterior wall MI and 11 
were inferior wall M1. 
Graph 7 
 
There is no significant difference between anterior wall and inferior wall 
MI  in relation to diabetes as a risk factor. 
 
DIABETES TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
TOTAL 32 21(66%) 11(34%) 
MALE 24 16(66.7%) 8(33.3%) 
FEMALE 8 5(62.5%) 3(37.5%) 
SMOKING(Graph 8) 
The role of smoking as a risk factor was also assessed 
 TOTAL ANTERIOR 
WALL 
INFERIOR  
WALL 
SMOKER 66 43(65%) 23(35%) 
 
Out of 84 males , 66(78.6%) were smokers .Out of 66 male smokers, 43 
were anterior wall MI and 23 were inferior wall MI. 
Graph 8 
 
There is no significant difference between anterior wall and inferior wall 
MI  in relation to smoking as a risk factor. 
 
BODY MASS INDEX (BMI)(Graph 9) 
The Body Mass Index (BMI) was calculated by dividing the patient’s 
body weight in kg by the square of patient’s height in metres. 
BMI = Weight (kg)/[Height(m)]
2
. According to patient’s BMI,they were  
divided into 4 groups 
BMI TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
UNDERWEIGHT(<18.5) 0 0 0 
NORMAL(18.5-24.9) 23 17(74%) 6(26%) 
OVERWEIGHT(25-29.9) 61 36(59%) 25(41%) 
OBESE(>30) 16 12(75%) 4(25%) 
 
Out of the 100 patients ,61 were overweight ,of which 36 were anterior 
wall MI and 25 were inferior wall MI.16 patients were obese ,of which 
12 were anterior wall MI and 4 were inferior wall MI.  
Graph 9 
 
There is no significant difference between anterior wall and inferior wall 
MI  in relation to BMI as a risk factor. 
 
SYSTOLIC BP  (Graph 10) 
SBP (mmHg) TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
<120 18 4(22.2%) 14(77.8%) 
120-140 38 20(52.6%) 18(47.4%) 
140 -160 24 21(87.5%) 3(12.5%) 
>160 20 20(100%) 0 
 
Out of the 100 patients, 38 had SBP between 120 and 140, of which 20 
were anterior wall MI and 18 were inferior wall MI. 
Graph 10 
 
There is a significant difference in systolic BP between anterior and 
inferior wall MI with a chi square value of 33.14 and p value < 0.001. 
 
 
 
DIASTOLIC BP(Graph 11) 
DBP (mmHg) TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
<80 22 6(27.3%) 16(72.7%) 
80-90 36 19(52.8%) 17(47.2%) 
90 -100 26 24(92.3%) 2(7.7%) 
>100 16 16(100%) 0 
 
Out of the 100 patients,36 had DBP between 80 and 90, of which 19 
were anterior wall  MI and 17 were inferior wall MI. 
Graph 11 
 
There is a significant difference in diastolic BP between anterior and 
inferior wall MI with a chi square value of 30.91 and p value <0.001. 
 
 
HYPERLIPIDEMIA(Graph 12) 
Hyperlipidemia as a risk factor was studied by measuring the lipid 
profile . Total cholesterol >200mg/dl,triglycerides.160 mg/dl,HDL < 40 
mg/dl were considered as risk factors. 
LIPID PROFILE 
(mg/dl) 
TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
s.cholesterol >200 44 30(68.2%) 14(31.8%) 
Triglycerides >160 33 21(63.6%) 12(36.4%) 
HDL <40 27 17(63%) 10(37%) 
 
44 patients had hypercholesterolemia, of which 30 were anterior wall and 
14 were inferior wall MI. 33 patients had hypertriglyceridemia of which 
21 were anterior wall and 12 were inferior wall MI. 27 patients had low 
HDL of which 17 were anterior wall and 10 were inferior wall MI. 
Graph 12 
 
There is no significant difference between anterior wall and inferior wall 
MI  in relation to lipid profile as a risk factor. 
RISK FACTORS 
 
RISK 
FACTORS 
SITE N MEAN Std 
deviation 
t p 
BMI AW 65 26.99 2.665 0.341 0.734 
IW 35 27.16 2.056 
SBP AW 65 147.75 20.909 7.298 <0.001 
IW 35 115.20 21.953 
DBP AW 65 93.26 10.946 7.321 <0.001 
IW 35 76.63 10.625 
Total 
cholesterol 
AW 65 203.95 35.485 0.441 0.660 
IW 35 200.77 32.249 
Triglycerides AW 65 149.78 18.729 0.783 0.436 
IW 35 152.80 17.691 
HDL AW 65 44.97 8.595 0.400 0.690 
IW 35 44.23 9.277 
 
 The t value 7.298 for the mean difference in systolic BP between 
anterior and inferior wall MI is significant (p<0.001).It reveals that 
patients with anterior wall MI have higher systolic BP when compared 
to inferior wall MI. 
 The t value 7.321 for the mean difference in diastolic BP between 
anterior and inferior wall MI is significant (p<0.001).It reveals that 
patients with anterior wall MI have higher diastolic BP when compared 
to inferior wall MI. 
The effect of the other risk factors was not significant. 
KILLIP’S CLASSIFICATION(Graph 13) 
 
The patients were divided into 4 classes based on Killip’s classification 
Class Definition Approx 
mortality(%) 
Class I Absence of rales over lung fields 
and absence of S3 
8 
Class II Rales over 50% or less of lung 
fields or presence of S3 
30 
Class III Rales over more than 50% of lung 
fields(pulmonary edema) 
44 
Class IV Cardiogenic shock 80 to 100 
 
KILLIP’S 
CLASS 
TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
CLASS I 42 27(65.3%) 15(34.7%) 
CLASS II 35 23(65.7%) 12(34.3%) 
CLASS III 11 6(55.5%) 5(45.5%) 
CLASS IV 12 9(75%) 3(25%) 
 
Out of the 100 patients, 42 were in class I, of which 27 were anterior wall 
MI and 15 were inferior wall MI.35 were in class II ,of which 23 were 
anterior wall and 12 were inferior wall MI. 11 were in class III, of which 
6 were anterior wall and 5 were inferior wall MI.12 were in class IV , of 
which 9 were anterior wall and 3 were inferior wall MI. 
 
Graph 13 
 
 
 
 
There is no significant difference between anterior wall and inferior wall 
MI  in relation to Killip’s classification. 
TACHYARRHYTHMIAS(Graph 14) 
The incidence of various types of tachyarrhythmias was assessed. 
TACHYARRHYTHMIA TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
Atrial fibrillation 2(4%) 2(100%) 0 
Supraventricular 
tachycardia 
6(12%) 4(66.7%) 2(33.3%) 
Ventricular extrasystole 30(60%) 20(66.7%) 10(33.3%) 
Ventricular 
tachycardia/fibrillation 
12(24%) 10(83.3%) 2(16.7%) 
TOTAL 50 36(72%) 14(28%) 
 
Out of the 50 patients with tachyarrhythmias, 36 were anterior wall MI 
and 14 were inferior wall MI.30 had ventricular extrasystole, of which 20 
were anterior wall MI and 10 were inferior wall MI.  
Graph 14 
 
Tachyarrhythmias were more common in anterior wall MI than in 
inferior wall MI . 
 
HEART BLOCK(Graph 15) 
The incidence of various heart blocks was assessed. 
HEART 
BLOCK 
TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
1º AV 
BLOCK 
3(16.7%) 0 3(100%) 
2º AV 
BLOCK 
2(11.1%) 0 2(100%) 
COMPLETE 
HEART 
BLOCK 
5(27.8%) 1(20%) 4(80%) 
RBBB 4(22.2%) 1(25%) 3(75%) 
LBBB 4(22.2%) 4(100%) 0 
TOTAL 18 6(33.3%) 12(66.7%)  
 
Out of the 18 patients with heart blocks,12 were inferior wall MI and 6 
were anterior wall MI. 
Graph 15 
 
Heart blocks were more common in inferior wall MI than in anterior 
wall MI. 
 
 
 
OTHER COMPLICATIONS(Graph 16) 
Other complications were also assessed. 
COMPLICATIONS TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
PMD and acute MR 3(20%) 3(100%) 0 
Septal perforation 2(13.3%) 2(100%) 0 
Ventricular 
aneurysm 
1(6.7%) 1(100%) 0 
RV Infarction 7(46.7%) 0 7(100%) 
Pericarditis 2(13.3%) 2(100%) 0 
TOTAL 15 8(53.3%) 7(46.7%) 
 
Out of the  15 other complications, 8 were anterior wall MI and 7 were 
inferior wall MI. 
Graph 16 
 
Anterior wall MI  had more incidence of other complications when 
compared to inferior wall MI . 
 
 
 
MORTALITY 
The mortality of the patients was studied in relation to age 
,sex,arrhythmias and killip class.(Graph 17) 
TOTAL DEATHS ANTERIOR 
WALL 
INFERIOR 
WALL 
18 13(72.2%) 5(27.8%) 
 
Out of the 18 deaths,13 were anterior wall MI and 5 were inferior wall 
MI. 
Graph 17 
  
 
 
 
AGE (yrs) TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
>70 3(16.7%) 2(66.7%) 1(33.3%) 
60-70 4(22.2%) 3(75%) 1(25%) 
50-60 8(44.4%) 5(62.5%) 3((37.5%) 
40-50 2(11.1%) 2(100%) 0 
30-40 1(5.6%) 1(100%) 0 
<30 0 0 0 
 
Out of the 18 deaths,8 were between 50 and 60 , of which 5 were 
anterior wall MI  and 3 were inferior wall MI.   
Graph 18 
 
  
SEX TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
MALE 15(83.3%) 10(66.7%) 5(33.3%) 
FEMALE 3(16.7%) 3(100%) 0 
 
Out of the 18 deaths, 15 were male,of which 10 were anterior wall and 5 
were inferior wall MI. 
 
Graph 19 
 
 ARRHYTHMIA TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
Ventricular 
tachycardia/fibrillation 
7(88.9%) 6(85.7%) 1(14.3%) 
Complete heart block 2(11.1%) 0 2(100%) 
 
Out of the 18 deaths, 7 were due to ventricular tachycardia/ventricular 
fibrillation, of which 6 were  anterior wall and 1 was inferior wall MI. 
 
Graph 20 
 
 
 KILLIP CLASS TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
CLASS I 1(5.5%) 1(100%) 0 
CLASS II 3(16.7%) 2(66.7%) 1(33.3%) 
CLASS III 3(16.7%) 1(33.3%) 2(66.7%) 
CLASS IV 11(61.1%) 8(72.7%) 3(27.3%) 
 
11 deaths were in killip class IV ,of which 8 were anterior wall and 3 
were inferior wall MI. 
Graph 21 
 
 
CHEST X RAY 
Chest X ray  was reported as normal or cardiomegaly. 
CXR TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
NORMAL 74 47(63.5%) 27(36.5%) 
CARDIOMEGALY 26 18(69.2%) 8(30.8%) 
 
26 patients had cardiomegaly ,of which 18 were anterior wall and 8 
were inferior wall MI. 
 
Graph 22 
 
 
 
More of anterior wall MI patients had cardiomegaly when compared to 
inferior wall MI. 
 
ECHOCARDIOGRAM (Graph 23) 
Echo was taken for the patients and grouped according to echo findings 
 
ECHO 
FINDING 
TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
RWMA 74 47(63.5%) 27(36.5%) 
RWMA + LVF 
 
23 15(65.2%) 8(34.8%) 
RWMA +PMD 3 3(100%) 0 
 
RWMA was present in 74 patients of which 47 were anterior wall and 
27 were inferior wall MI 
 
Graph 23 
 
 
More of anterior wall MI patients had RWMA when compared to 
inferior wall MI. 
EJECTION FRACTION(EF)(Graph 24) 
 
Ejection fraction was estimated using echo. 
EJECTION 
FRACTION (%) 
TOTAL ANTERIOR 
WALL 
INFERIOR 
WALL 
NORMAL(55 -
70%) 
73 47(64.4%) 26(35.6%) 
LOW (<55%) 27 18(66.7%) 99(33.3%) 
 
27 patients had low EF, of which 18 were anterior wall and 9 were 
inferior wall MI. 
 
 
Graph 24 
 
 
 
More of anterior wall MI patients had low EF when compared to inferior 
wall MI. 
  
 
 
 
 
 
 
 
 
 
 
 
Discussion                        
DISCUSSION 
 
Anterior wall MI is generally considered to have a poor prognosis 
and higher mortality when compared to inferior wall MI. In the present 
study, anterior and inferior wall MI patients are compared in terms of age, 
sex ,risk factors, complications and mortality. 
 
In relation to age, Age is a definite unmodifiable risk factor. 
Atherosclerosis develops progressively as age advances. According to 
Prasanth etal53 , South Asians develop AMI at an earlier age when 
compared to other countries and the mean age was 53 years. In my study, 
AMI was highest in the age group of 50-60 yrs(39%) ,which was 
comparable  with the above mentioned study. But there was no significant 
difference between  anterior wall and inferior wall MI in relation to age. 
 
In relation to sex, Men are more affected than premenopausal 
women. However after menopause the incidence of atheroma rises in 
women. According to Sonia etal
55
 , MI occurs more in males and earlier 
in males. In my study also, the incidence of  MI was more in males (84%) 
which was comparable with the above mentioned study. But there was no 
significant difference  between  anterior wall and inferior wall MI in 
relation to sex . 
In relation to occupation, previously sedentary work used to be 
considered a risk factor for MI, but now even heavy workers are being 
affected. In my study, manual labourers (66%) have highest incidence of  
MI , which is correlating. But there was no significant difference between 
anterior wall and inferior wall MI in relation to occupation . 
 
In relation to site,  according to Peter etal
99
 , anterior wall MI is  
more common than inferior wall MI. In my study also, anterior wall MI 
(65%) was  more common than inferior wall MI. Out of  the anterior wall 
MI patients, majority were anteroseptal (46.2%) . 
 
In relation to hypertension , the incidence of coronary heart disease 
increases as blood pressure rises and the excess risk is related to both 
systolic and diastolic blood pressure  . According to Trenkwalder etal
67
, 
Hypertension is a significant risk factor for MI and associated morbidity 
and mortality.In my study also ,hypertension was an important risk factor 
and was present in 51% of the patients. Out of this, majority(65%)  were 
anterior wall MI. But there was no significant difference between anterior 
wall and inferior wall MI  in relation to hypertension as a risk factor. 
 
In relation to diabetes, Diabetes Mellitus is a coronary heart disease 
risk equivalent . According to Lundberg etal
74
, Diabetes is  a significant 
risk factor for MI and associated morbidity and mortality. In my study  
,Diabetes was present in 32% of cases, out of which, majority were  
anterior wall MI (66%). So diabetes was a significant risk factor for MI. 
But there was no significant difference between anterior wall and inferior 
wall MI  in relation to diabetes as a risk factor. 
 
 In relation to smoking, there is a strong, consistent and dose linked 
relationship between cigarette smoking
 
 and Ischaemic heart disease . 
According to Prescott etal
62
 , smoking is  a significant risk factor for MI 
and associated morbidity and mortality. In my study  , 66(78.6%) of the 
males were smokers, out of which 43(65%) were anterior wall MI .So 
smoking was a significant risk factor for MI. But there was no significant 
difference between anterior wall and inferior wall MI  in relation to 
smoking as a risk factor. 
 
 In relation to obesity , particularly the male pattern of centripetal or 
visceral fat accumulation is probably an independent risk factor for CHD. 
According to Lavie  etal
80
 ,Obesity is a significant risk factor for MI and 
associated morbidity and mortality . In my study,  BMI was used for 
assessing obesity and 61% of the patients  were overweight ,of which 
66%  were anterior wall MI.16% of the patients were obese ,of which 
75% were anterior wall MI .So obesity was a significant risk factor for 
MI . But there was no significant difference between anterior wall and 
inferior wall MI  in relation to BMI as a risk factor. 
 In relation to Systolic BP ,anterior wall MI patients have higher 
SBP where as inferior wall MI  patients have lower SBP usually because 
of vagal stimulation. In my study , 38 % of the patients  had  SBP 
between 120 and 140, of which  20 (52.6%) were anterior wall MI. The 
mean SBP of AWMI patients was 147.75 mmHg and the mean SBP of 
IWMI patients was 93.26 mmHg. So there was a significant difference in 
systolic BP between anterior and inferior wall MI with a chi square value 
of 33.14 and p value < 0.001, which was comparable with previous 
studies. 
 
 In relation to Diastolic BP, anterior wall MI patients have higher 
DBP where as inferior wall MI patients have lower DBP usually because 
of vagal stimulation . In my study, 36% of the patients had DBP between 
80 and 90, of which 19(52.8%) were anterior wall MI . The mean DBP of 
AWMI patients was 115.20 mmHg and the mean DBP of IWMI patients 
was 76.63 mmHg. So there was a significant difference in diastolic BP 
between anterior and inferior wall MI with a chi square value of 30.91 
and p value <0.001, which was comparable with previous studies. 
 
 In relation to lipid profile, A wealth of evidence from 
epidemiological, clinical and experimental studies has established the 
association between hyperlipidemia and atherosclerosis.According to 
Goldstein etal
71
 , hypercholesterolemia and hypertriglyceridemia are 
important risk factors  for MI . In my study , 44% of the patients had 
hypercholesterolemia, of which 30 (68.2%) were anterior wall MI, 33% 
of the patients had hypertriglyceridemia of which 21(63.6%) were 
anterior wall MI and 27% of the  patients had low HDL of which 
17(63%) were anterior wall MI. So hypercholesterolemia, 
hypertriglyceridemia and low HDL were significant risk factors for MI. 
But  there was no significant difference between anterior wall and inferior 
wall MI  in relation to lipid profile as a risk factor. 
 
 In relation to the various risk factors, the t value 7.298 for the mean 
difference in systolic BP between anterior and inferior wall MI was 
significant (p<0.001). It revealed that patients with anterior wall MI have 
higher systolic BP when compared to inferior wall MI .The t value 7.321 
for the mean difference in diastolic BP between anterior and inferior wall 
MI was also significant (p<0.001). It revealed  that patients with anterior 
wall MI have higher diastolic BP when compared to inferior wall MI. The 
effect of the other risk factors was not significant. 
 
 In relation to Killip’s Classification of  heart failure, According to 
the original Killip study
98
 , majority of the patients were in class II 
(38%).In my study, majority of the patients were in class I (42%), of 
which 27(65.3%)  were anterior wall MI .This difference might be 
because of better awareness of patients and early diagnosis and treatment 
. But there was no significant difference between anterior wall and 
inferior wall MI  in relation to Killip’s classification. 
 
 In relation to arrhythmias,  in general tachyarrhythmias are 
common in anterior wall MI, whereas bradyarrhythmias are more 
common in inferior wall MI.According to Siddique etal93, most common  
tachyarrhythmia in MI patients is ventricular extrasystole (56%). In my 
study, 50% of the patients had tachyarrhythmias, of which 36 (72%) were 
anterior wall MI. 30 (60%)  had ventricular extrasystole, of which 
20(66.7%) were anterior wall MI. So tachyarrythmias were more 
common in anterior wall MI and most common tachyarrythmia was 
ventricular extrasystole. This was comparable with the above mentioned 
study. 
 
 In relation to heart blocks,in general heart blocks are more 
common in inferior wall MI. According to Siddique etal
93
, most common 
heart block in MI patients is complete heart block. In my study,18% of 
patients had heart blocks, of which 12 (66.7%)were inferior wall MI. So 
heart blocks were more common in inferior wall MI and most common 
heart block was complete heart block (27.8%) .This was comparable with 
the above mentioned study. 
 In relation to the other complications, in general anterior wall MI 
has more complications when compared to inferior wall MI. Stone etal
97
 
said that patients with anterior infarction had a substantially worse in-
hospital and follow-up clinical course compared with those with inferior 
infarction, evidenced by a larger infarct size , lower admission left 
ventricular ejection fraction , higher incidence of heart failure , serious 
ventricular ectopic activity , in-hospital death  and total cumulative 
cardiac mortality.In my study, 15 % of patients had other 
complications,of which 8 (53.3%)were anterior wall MI. The most 
common other complication was RV infarction. So anterior wall MI  had 
more incidence of other complications when compared to inferior wall 
MI. 
 
In relation to mortality, in general, anterior wall MI has a higher 
mortality when compared to inferior wall MI.Stone etal
97
 said that 
anterior wall MI has more mortality than inferior wall MI. In my 
study,18% of the patients died , of which 13(72.2%) were anterior wall 
MI  .Out of the deaths, 8 (44.4%)were between 50 and 60 years of age , 
of which 5(62.5%) were anterior wall MI .15(83.3%) deaths were males 
of which 10(66.7%) were anterior wall MI. 7 (88.9%)deaths were due to 
VT/VF,of which 6 (85.7%) were anterior wall MI.11 (61.1%)deaths were 
in killip class IV ,of which 8 were anterior wall MI. In killip original 
study , the mortality was 67% for killip class IV, which was comparable.  
So anterior wall MI had more mortality when compared to inferior wall 
MI. The above observations were comparable with previous studies. 
 
 In relation to Chest X Ray,28 patients had cardiomegaly ,of which 
18(69.2%) were anterior wall MI. More of anterior wall MI patients had 
cardiomegaly when compared to inferior wall MI. 
 
In relation to ECHO, RWMA was present in 74 patients of which 
47(63.5%) were anterior wall MI. More of anterior wall MI patients had 
RWMA when compared to inferior wall MI. 
 
 In relation to Ejection fraction , 27 patients had low EF, of which 
18(66.7%) were anterior wall MI. More of anterior wall MI patients had 
low EF when compared to inferior wall MI. 
  
 
 
 
 
 
 
 
 
 
 
 
Summary         
SUMMARY 
1) The incidence of anterior wall MI is more than inferior wall MI 
(65:35). 
2) The incidence of MI is highest in the age group of 50-60 years(39%) 
and more in males(84%). 
3) The incidence of MI is more among manual labourers(66%). 
4) The incidence of MI is more among smokers(78.6%) and those with 
other risk factors such as obesity,hypertension,diabetes,hyperlipidemia 
etc. 
5) Systolic and diastolic BP are higher in anterior wall MI when 
compared to inferior wall MI. 
6) Tachyarrhythmias and other complications are more common in 
anterior wall MI , whereas heartblocks are more common in inferior 
wall MI. 
7) Majority of the patients admitted in ICCU are in Class I based on 
Killip’s classification(42%). 
8) Mortality is high in anterior(72.2%) when compared to inferior wall 
MI. 
9) Mortality is high in the age group 50-60 years(44.4%) and more in 
males(83.3%) 
10) Mortality is high in Class IV Killip(61.1%) patients and more due 
to VT/VF(88.9%) 
  
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion           
CONCLUSION 
 
 
The overall incidence of anterior wall MI is much more than inferior 
wall MI. Also complications such as arrhythmias and mortality are much 
more in anterior wall MI than in inferior wall MI. Hence more care 
should be taken and close monitoring and early treatment should be 
instituted in all patients with anterior wall MI. 
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Appendix   
CONSENT FORM 
DEPARTMENT OF GENERAL MEDICINE ,  
COIMBATORE MEDICAL COLLEGE HOSPITAL. 
COMPARATIVE STUDY OF ANTERIOR AND INFERIOR WALL 
MYOCARDIAL INFARCTION 
Informed consent form for prospective participants 
Principal Investigator: Dr Himal Raj.M ,  Junior Resident. 
Research Guide:  Prof. Dr S.Usha.MD. Chief, Medical Unit – III 
Organization:  Department of Medicine, Coimbatore Medical 
College Hospital. 
This informed consent form has two parts 
PART – I  INFORMATION SHEET(to share the information about the 
research with you) 
PART – II CERTIFICATE OF CONSENT (for signatures if you agree to 
take part) 
(You will be given a copy of the full informed consent form.) 
 
 
PART – I  INFORMATION SHEET 
I , Dr Himal Raj.M., Junior resident in Dept of Medicine invites you to 
join as participant in my research on Myocardial infarction, which is a 
very common problem in our country. I am going to give you information 
and invite you to be part of this research. You do not have to decide today 
whether or not you will participate in the research. Before you decide, 
you can talk to anyone you feel comfortable with about the research.  
There may be some words that you do not understand. Please ask me to 
stop as we go through the information and I will take time to explain.  If 
you have questions later, you can ask them of me, the study doctor or the 
staff. 
Myocardial infarction is a a disease characterized by infarction and 
necrosis of the myocardium secondary to occlusion of the coronary blood 
vessels.It can involve either anterior wall or inferior wall.It could be fatal 
if left untreated . We are doing this research to compare the incidence 
,outcome and prognosis of anterior and inferior wall myocardial 
infarction and thereby focus our prevention and treatment efforts in a 
better way. 
In this study you will have to answer questions regarding your illness, 
undergo a physical examination , give urine and blood for tests, undergo a 
radiological exam of chest, an electrocardiogram and an echocardiogram. 
Your participation in this research is entirely voluntary. It is your choice 
whether to participate or not. Whether you choose to participate or not, all 
the services you receive at this clinic will continue and nothing will 
change. You may change your mind later and stop participating even if 
you agreed earlier. 
You will have to give details regarding your age, duration of disease, 
family history of the disease, any symptoms you are having at present, 
your past medical problems, surgeries and current medications. A doctor 
will examine you to look for any problems.. All the data will be recorded 
in a proforma. Ten ml of blood will be drawn for doing various laboratory 
tests to know about the status of your disease. Any excess sample will be 
destroyed immediately after the laboratory tests are completed. Taking 
the blood sample will produce some pain and there may be slight redness 
at the site of puncture for a day or two. Also you will have to provide 3 
ml or urine for tests to detect protein. You will be subjected to a  
radiological exam of the chest, an electrocardiogram(ECG) and an 
echocardiogram will be recorded all of which are painless procedures. 
On the first day you will be asked about your problems, a doctor will 
check you up and an ECG will be taken. You will also have to give the 
blood and urine samples. Subsequently,  chest X ray and Echocardiogram 
will also be taken. 
If you participate in this research you will be having a thorough check up, 
which may reveal some unidentified problems in you. We will promptly 
start the treatment for them. Also by participating you are providing 
valuable data that will help doctors understand this disease better and 
ultimately serve the patients in a better way. 
We will not be providing any money for participating in this research, 
you may incur more expense since you will have to visit the hospital 
more frequently. 
It is possible that if others in the community are aware that you are 
participating in this research, they may ask you questions. We will not be 
sharing the identity of those participating in the research with anyone. 
The information that we collect from this research project will be kept 
confidential. Information about you that will be collected during the 
research will not be identified by your name but by a number. Only the 
researchers will know what your number is and they will lock that 
information up with a lock and key. It will not be shared with or given to 
anyone except my research guide. 
The knowledge that we get from doing this research will be shared with 
you before it is made widely available to the public. Confidential 
information will not be shared. There will be small meetings in the 
community and these will be announced. After these meetings, we will 
publish the results in order that other interested people may learn from 
our research 
You do not have to take part in this research if you do not wish to do so. 
You may also stop participating in the research at any time you choose. It 
is your choice and all of your rights will still be respected. 
 
If you have any questions you may ask them now or later, even after the 
study has started. If you wish to ask questions later, you may contact  
 
 
Dr Himal Raj M,         Prof .Dr. S.Usha.MD. 
Junior Resident,                  Chief, Medical Unit – III, 
Dept Of Medicine,         Dept Of Medicine, 
Coimbatore Medical College Hospital      Coimbatore Medical College 
Hospital, 
Coimbatore – 18.         Coimbatore- 18. 
Phone – 9894295330        Phone – 9865980015 
 
This proposal has been reviewed and approved by the Ethics Committee 
of Coimbatore Medical College Hospital which is a committee whose 
task it is to make sure that research participants are protected from harm. 
 
PART – II CERTIFICATE OF CONSENT 
 
I have been invited to participate in research on myocardial infarction. I 
understand that it will involve answering a detailed questionnaire, 
undergoing a thorough physical exam, giving blood and urine samples ,an 
ECG,CXR and an ECHO. I have been informed that the risks are minimal 
and may include only slight pain and redness at sight of needle prick. I 
am aware that there may be no benefit to me personally and that I will not 
be compensated monetarily. I have been provided with the name of a 
researcher who can be easily contacted using the number and address I 
was given for that person. 
 
I have read the foregoing information or it has been read to me. I have 
had the opportunity to ask questions about it and any questions I have 
asked have been answered to my satisfaction. I consent voluntarily to 
participate as a participant in this research and understand that I have the 
right to withdraw from the research at  anytime without in anyway 
affecting my medical care. 
Name of the participant: 
 ________________________________________________ 
Signature of the participant:
 ________________________________________________ 
Date:   
 ________________________________________________ 
     (Day/Month/Year) 
If illiterate 
A literate witness must sign (if possible , this person should be selected 
by the participant and must have no connection to the research team) 
I have witnessed the accurate reading of the consent form to the potential 
participant , translated to his mother tongue,  and the individual has had 
opportunity to ask questions. I confirm that the individual has given 
consent freely. 
Name of witness: _________________________     AND        Thumb 
print of participant 
Signature of witness: _________________________ 
Date :   _________________________ 
   (Day/Month/Year) 
I have accurately read or witnessed the accurate reading of the consent 
form to the potential participant, and the individual has had the 
opportunity to ask questions. I confirm that the individual has given 
consent freely. 
Name of the researcher: 
 ______________________________________ 
Signature of the researcher:
 ______________________________________ 
Date: ______________________________________ 
    (Day/Month/Year) 
PROFORMA 
     
NAME :                                                       AGE  :                              
SEX: M/F    
IP NO:                            DOA:                               DOD: 
OCCUPATION: 
DIAGNOSIS: 
WINDOW PERIOD: 
PRESENTING COMPLAINTS : 
CHEST PAIN: 
          DURATION: 
          LOCATION: 
          RADIATION 
ASSOCIATED  SYMPTOMS : 
          SWEATING 
          PALPITATION 
          DYSPNEA 
          PND,ORTHOPNEA 
          SYNCOPE 
          GIDDINESS 
          NAUSEA & VOMITING 
HISTORY OF PRESENT ILLNESS : 
PAST HISTORY : SHT / DM / COPD 
SMOKING: 
ALCOHOL   CONSUMPTION: 
DIET: VEG/NON VEG/MIXED 
MENSTRUAL HISTORY: 
FAMILY HISTORY: IHD/OBESITY/DM/SHT/HYPERLIPIDEMIA  
TREATMENT HISTORY:  DRUG INTAKE 
GENERAL EXAMINATION: 
DYSPNEA/PALLOR/JAUNDICE/CYANOSIS/CLUBBING/PEDAL 
EDEMA 
XANTHALESMA / TENDON XANTHOMAS/ ARCUS SENILIS 
 
THYROID 
 
PULSE: 
BLOOD PRESSURE :                        HEIGHT:                   WEIGHT:               
BMI: 
RESPIRATORY RATE:                       WAIST CIRCUMFERENCE: 
TEMPERATURE:                                 WAIST HIP RATIO: 
SYSTEM EXAMINATION 
CARDIOVASCULAR SYSTEM  
 APICAL IMPULSE:                      S1:                 S2:              S3 :   
 MURMUR:             ADDED  SOUNDS:                 PERICARDIAL 
RUB: 
PERIPHERAL VASCULAR SYSTEM: 
 
RESPIRATORY SYSTEM 
                          BREATH SOUNDS: 
                          ADVENTITIOUS SOUNDS: 
 ABDOMINAL EXAMINATION 
                          ORGANOMEGALY: 
                          FREE FLUID:    
NERVOUS SYSTEM 
                        ANY FOCAL NEUROLOGICAL DEFICITS:                   
FUNDUS: 
INVESTIGATIONS 
Hb:               TC:          DC:            ESR: 
RBS: 
BLOOD UREA:                  SERUM CREATININE: 
S.ELECTROLYTES: 
LIPID PROFILE:              S.CHOLESTEROL:                   
S.TRIGLYCERIDES: 
URINE ROUTINE: 
ECG: 
 AT THE TIME OF ADMISSION: 
PRESENCE OF ARRHYTHMIAS 
LOCATION OF MYOCARDIAL INFARCTION: 
AFTER THROMBOLYSIS: 
 
CXR (PA VIEW): 
 
ECHOCARDIOGRAM 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Master Chart         


ABBREVIATIONS 
 
1ºAV Block – First degree Atrioventricular Block 
2º AV Block – Second degree Atrioventricular Block 
AHA – American Heart Association 
AMI – Acute Myocardial infarction 
AW – Anterior Wall 
BMI – Body Mass Index 
CHD – Coronary Heart Disease 
CRP – C Reactive protein 
CKMB – Creatine kinase MB fraction 
CXR – Chest X Ray 
DBP – Diastolic Blood Pressure 
DM – Diabetes Mellitus 
ECG – Electrocardiogram 
ECHO – Echocardiogram 
EF – Ejection Fraction 
ESR – Erythrocyte sedimentation rate 
HDL – High Density Lipoprotein 
HOCM – Hypertrophic Obstructive Cardiomyopathy 
ICCU – Intensive Coronary Care Unit 
IW – Inferior Wall 
LAD – Left Anterior Descending artery 
LBBB – Left Bundle Branch Block 
LCA – Left Coronary Artery 
LVF – Left Ventricular Failure 
MI –  Myocardial infarction 
MR – Mitral Regurgitation 
NQMI – Non Q wave Myocardial infarction 
NSTEMI – Non ST segment Elevation Myocardial infarction 
PCI – Percutaneous Coronary Intervention 
PMD – Papillary Muscle Dysfunction 
QwMI – Q wave Myocardial infarction 
RBBB – Right Bundle Branch Block 
RCA – Right Coronary Artery 
RV – Right Ventricle 
RWMA – Regional Wall Motion Abnormality 
SBP – Systolic Blood Pressure 
SHT – Systemic Hypertension 
SLE – Systemic Lupus Erythematosis 
STEMI – ST segment Elevation Myocardial infarction 
VT –Ventricular Tachycardia 
VF – Ventricular Fibrillation 
MASTER CHART 
Occupation – 1-sedentary work 
     2-moderate exertion 
                3-manual labourer 
Site – A- Anterior wall MI 
 I-Inferior wall MI                        
SHT- Systemic Hypertension 
         P-Present           A-Absent 
DM – Diabetes Mellitus 
          P-Present           A-Absent 
Smoking – 
           P-Present           A-Absent 
BMI – Body Mass Index 
SBP – Systolic Blood Pressure 
DBP – Diastolic Blood Pressure 
TC – Total Cholesterol 
TG – Triglycerides 
HDL- High Density Lipoprotein 
Killip class – 1-Class I    2-ClassII    3-ClassIII    4-ClassIV 
 
Arrhythmias -  1-Atrial fibrillation    2-Supraventricular tachycardia 
                   3-Ventricular extrasystole   4- Ventricular  
tachycardia/fibrillation 
Heart blocks  - 1-1
st
  degree heart block   2-2
nd
 degree heart block 
  3-Complete heart block       4- Right bundle branch block(RBBB) 
  5 – Left bundle branch block(LBBB) 
Other complications - 
1-Papillary muscle dysfunction (PMD)& acute mitral regurgitation(MR) 
2-Septal perforation     3-Ventricular aneurysm 
4-RV Infarction    5-Pericarditis 
Death – D –Death 
CXR –Chest XRay     N-Normal            C-Cardiomegaly 
ECHO – Echocardiogram 
              R – Regional Wall Motion Abnormality(RWMA) 
              RL- RWMA + Left Ventricular Failure(LVF) 
              RP – RWMA +Papillary Muscle Dysfunction(PMD) 
 
 
 
